Dementia
Showing NaN - NaN of 11
Dementia, Cognitive Impairment, Mild, Dementia, Vascular Trial in Farmington, New Haven (Referral for Cognitive Stimulation
Enrolling by invitation
- Dementia
- +8 more
- Referral for Cognitive Stimulation Therapy
- No change to Standard of Care
-
Farmington, Connecticut
- +1 more
May 16, 2023
Alzheimer, Cognitive Dysfunction, Dementia Trial in Worldwide (JNJ-63733657, Placebo)
Recruiting
- Alzheimer Disease
- +2 more
- JNJ-63733657
- Placebo
-
Birmingham, Alabama
- +143 more
Jan 31, 2023
Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Matching Placebo (Gantenerumab))
Suspended
- Alzheimers Disease
- +2 more
- Gantenerumab
- Matching Placebo (Gantenerumab)
-
Birmingham, Alabama
- +34 more
Jan 10, 2023
Cognitive Impairment, Emergency Care, Dementia Trial in New Haven, Chicago (PD4ED 3-step intervention (ED assessment, outpatient
Completed
- Cognitive Impairment
- +3 more
- PD4ED 3-step intervention (ED assessment, outpatient assessment, Brain health plan)
-
New Haven, Connecticut
- +1 more
Nov 1, 2022
Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo
Families Coping Together With Alzheimer's Disease
Recruiting
- Family Research
- Dementia
-
New Haven, ConnecticutYale school of Public Health
Oct 7, 2021
(Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid
Completed
- Alzheimer's Disease
- Dementia
- Placebo
- donepezil (Aricept)
-
New Haven, ConnecticutPfizer Investigational Site
Feb 10, 2011